Connecting Innovation and Investment: Dendrogenix at Bio Investment Convention organized by Sambrinvest

Posted on : |

Dendrogenix team had the pleasure of participating in the Sambrinvest Bio Investment Convention on October 16, 2025 , where innovation, entrepreneurship, and investment came together to spark new opportunities. We had the chance to present our mission to develop cutting-edge innovative therapies in hearing-loss area and to connect with passionate investors and partners who share our vision for improving patients’ lives. A big thank you to Sambrinvest for organizing such a high-impact event and to everyone who stopped by to discuss science, strategy, and growth with us.

DENDROGENIX S.A.

Founded in 2018, Dendrogenix develop first-in-class molecules, Dendrogenins, to address high unmet medical needs in hearing loss and neurology.

© 2024 Dendrogenix